Table 4.
Men | Women | |||||
---|---|---|---|---|---|---|
β | p | AOR (95% CI)* | β | p | AOR (95% CI)* | |
Disordered opiate use | ||||||
CA | ||||||
None** | - | - | - | - | - | - |
1–2 types | 0.97 | 0.183 | 2.63 (0.63–11.01) | 0.91 | 0.114 | 2.48 (0.81–7.71) |
3 or more types | 1.40 | 0.083 | 4.04 (0.83–19.67) | 1.32 | 0.063 | 3.75 (0.93–15.16) |
Major stressors | ||||||
None** | - | - | - | - | - | - |
1 to 2 | 1.55 | 0.015 | 4.73 (1.37–16.36) | 0.71 | 0.244 | 2.04 (0.61–6.84) |
3 or more | 1.35 | 0.153 | 3.84 (0.60–24.61) | 1.31 | 0.128 | 3.71 (0.68–20.21) |
Χ24 (p value)*** | 2.90 | 0.575 | 0.59 | 0.964 | ||
Disordered cannabis use | ||||||
CA | ||||||
None** | - | - | - | - | - | - |
1–2 types | 0.78 | 0.005 | 2.17 (1.28–3.69) | 2.34 | <0.001 | 10.37 (4.03–26.65) |
3 or more types | 1.24 | <0.001 | 3.45 (1.84–6.49) | 2.96 | <0.001 | 19.29 (6.04–61.56) |
Major stressors | ||||||
None** | - | - | - | - | - | - |
1 to 2 | 1.00 | <0.001 | 2.72 (1.69–4.37) | 1.58 | 0.009 | 4.83 (1.49–15.66) |
3 or more | 0.92 | 0.023 | 2.51 (1.14–5.51) | 2.50 | 0.002 | 12.20 (2.71–54.98) |
Χ24 (p value)*** | 5.70 | 0.223 | 2.91 | 0.572 | ||
Disordered stimulant use | ||||||
CA | ||||||
None** | - | - | - | - | - | - |
1–2 types | 1.00 | 0.114 | 2.72 (0.78–9.47) | **** | **** | **** |
3 or more types | 1.45 | 0.072 | 4.27 (0.88–20.78) | 1.24 | 0.317 | 3.44 (0.30–39.87) |
Major stressors | ||||||
None** | - | - | - | - | - | - |
1 to 2 | 1.74 | 0.004 | 5.72 (1.77–18.53) | 1.38 | 0.107 | 4.20 (0.74–21.30) |
3 or more | 2.50 | <0.001 | 12.12 (3.00–49.03) | 3.39 | 0.001 | 32.72 (4.17–211.67) |
Χ24 (p value)*** | 3.16 | 0.531 | 94.41 | <0.001 |
AOR (95% CI) = adjusted odds ratios (95% confidence intervals), adjusted for age, race, nativity
Reference category
Χ2 test of the interactions between CA and past year stressors in models for 12 month disorders